Fuente: PubMed "royal jelly" Polymers (Basel). 2025 Oct 28;17(21):2872. doi: 10.3390/polym17212872.ABSTRACTThe fields of healthcare and pharmaceutical science are increasingly focused on developing innovative and effective treatments. This trend is driven by a growing consumer demand for natural, sustainable, and highly functional polymer-based products. This study focuses on two biomaterials: chitosan and royal jelly. Chitosan, a linear polysaccharide derived from chitin, is well-regarded for its hemostatic and antimicrobial properties, making it an excellent candidate for wound healing applications. Royal jelly, a nutrient-rich secretion from honeybees, represents a complex mixture of proteins, lipids, vitamins, and antioxidants, notably 10-hydroxy-2-decenoic acid (10-H2DA). It is known for its anti-inflammatory, antioxidant, and regenerative effects on the skin. While the individual benefits of chitosan and royal jelly are well-documented, there is a significant research gap concerning their synergistic application in various treatments such as topical formulations, wound healing, regenerative medicine, and delivery transport processes. Ultimately, this review concludes that the synergistic effects of chitosan and royal jelly could provide a material platform with a superior dual-action profile, integrating the structural and antimicrobial benefits of chitosan with the powerful regenerative and anti-inflammatory effects of royal jelly. This synergy strongly supports their utility in developing next-generation, high-performance natural bioproducts for wound healing, bone regeneration, agriculture, or aquaculture applications.PMID:41228633 | PMC:PMC12610130 | DOI:10.3390/polym17212872